Results for tag: "Lonsurf"

Lonsurf is a type of colon cancer drug used to treat metastatic colorectal cancer. It is a combination of two active ingredients, trifluridine and tipiracil hydrochloride, which work together to inhibit the growth of cancer cells. The drug is administered orally and is available in tablet form. It is used in combination with other chemotherapy drugs to treat metastatic colorectal cancer that has progressed after treatment with other chemotherapy drugs. Lonsurf is approved by the US Food and Drug Administration (FDA) and is available in many countries around the world. It is also approved for use in the European Union and Japan. The Lonsurf market is highly competitive, with many companies offering similar products. Some of the major players in the market include Taiho Pharmaceutical, Merck & Co., Pfizer, and AstraZeneca. Other companies in the market include Bristol-Myers Squibb, Novartis, and Eli Lilly. Show Less Read more